NCT06232083 2025-07-09A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)Anhui Provincial HospitalPhase 1 Recruiting20 enrolled